
Current Price | $4.02 | Mkt Cap | $90.6M |
---|---|---|---|
Open | $3.68 | P/E Ratio | -1.34 |
Prev. Close | $4.02 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $3.68 - $4.39 | Volume | 273,033 |
52-Wk Range | $2.19 - $5.80 | Avg. Daily Vol. | 138,537 |
Current Price | $4.02 | Mkt Cap | $90.6M |
---|---|---|---|
Open | $3.68 | P/E Ratio | -1.34 |
Prev. Close | $4.02 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $3.68 - $4.39 | Volume | 273,033 |
52-Wk Range | $2.19 - $5.80 | Avg. Daily Vol. | 138,537 |
The best Bull and Bear pitches based on recency and number of recommendations.
We've opened a tentative 1000 share position in Abeona with cost basis 6.8, but I have a lot of questions about this company which has arrived on trading desks via a reverse merger. Abeona has been developing AAV-based gene therapy for Sanfilippo… More
Redchip stock. Pump & Dump Trash.
Read the most recent pitches from players about ABEO.
Recs
Biotech firm desperately trying to find cures to a number of ocular and skin diseases (from what I can tell). They haven't got much revenue to mention, so they primarily get funds by issuing more and more stock every year. I'm happy to flag this as underperform. Their drugs don't seem like blockbuster items. As a member of an ethical society, I applaud their efforts. As an investor... I thumb thee down.
Recs
Redchip stock. Pump & Dump Trash.
Find the members with the highest scoring picks in ABEO.
See what the Wall Street professionals think, according to their public statements and filings.